期刊文献+

3种用药方案治疗念珠菌性阴道炎的最小成本分析 被引量:3

Cost-minimization Analyses of 3 Therapeutic Regimens for Candidal Vaginitis
原文传递
导出
摘要 目的:评价3种用药方案治疗念珠菌性阴道炎的经济学效果。方法:将我院门诊156例念珠菌性阴道炎患者随机分为A、B、C组,分别给予制霉菌素泡腾片、苦参栓、硝酸咪康唑栓+氟康唑胶囊治疗,观察各组治疗效果,并用最小成本法分析。结果:A、B、C组成本分别为199.00、322.30、201.80元,有效率分别为96.15%、92.31%、98.08%(P>0.05),痊愈率分别为55.77%、36.54%、88.46%,复发率分别为11.54%、25.00%、1.92%。结论:A组方案较经济,但综合比较C组方案最佳。 OBJECTIVE: To evaluate the cost- effectiveness of 3 therapeutic regimens in the treatment of candidal vaginitis. METHODS: A total of 156 outpatients with candidal vaginitis in our hospital were randomly assigned to receive Nystatin Vaginal Effervescent Tablets (Group A), Kushen Suppository (Group B) or Miconazole Nitrate Suppositories plus Fluconazole Capsules (Group C). The therapeutic efficacy was monitored and the cost -minimization analyses were performed. RESULTS: The costs for 3 groups (A, B and C) were 199.00 yuan, 322.30 yuan and 201.80 yuan, respectively; the effective rates were 96.15%, 92.31% and 98.08%, respectively(P 〉 0.05) ; the cure rates were 55.77%, 36.54% and 88.46%, respectively; the recurrence rates were 11.54%, 25.00% and 1.92%, respectively. CONCLUSION: Scheme A is the preferable one economically, however, taking all the factors into consideration, scheme C is the best one.
出处 《中国药房》 CAS CSCD 北大核心 2008年第32期2484-2486,共3页 China Pharmacy
关键词 最小成本分析 制霉菌素泡腾片 苦参栓 硝酸咪康唑栓 氟康唑胶囊 念珠菌性阴道炎 Cost -minimization analysis Nystatin vaginal effervescent tablets Kushen Suppository Miconazole nitrate suppositories Fluconazole capsules Candidal vaginitis
  • 相关文献

参考文献5

二级参考文献37

  • 1沈爱宗,张善堂,史天陆,屈建,陈礼明,陈飞虎.国内药物经济学文献计量学分析[J].药物流行病学杂志,2005,14(3):167-169. 被引量:8
  • 2王鋆,张钧.药物经济学成本-效果分析[J].药学实践杂志,1995,13(4):193-197. 被引量:462
  • 3[6]Aram VC, George LB, Henry RB, et al .The Seventh Report of the Joint National Committee on Prevention,Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report [J].JAMA, 2003, 289(19): 2 560. 被引量:1
  • 4Fidel PL Jr. Immunity in vaginal candidiasis[J]. Curr Opin Infect Dis,2005, 18(2): 107-111. 被引量:1
  • 5Barousse MM, Van Der Pol BJ, Fortenberry D, et al. Vaginal yeast colonisination, prevalence of vaginitis, and associated local immunity in adolescent[J]. Sex Transm Infect, 2004, 80(1): 48-53. 被引量:1
  • 6Fidel PL Jr, Barousse M, Louvev V, et al. Local immune responsiveness following intravaginal challenge with candida antigen in adult women at different stages of the menstrual cycle [J]. Med Mycol,2003, 41(2): 97-109. 被引量:1
  • 7Ibrahim AS, Spellberg BJ, Avenissian V, et al. Vaccination with recombinant N-terminal domain of Alslp improve survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral immunity[J]. Infect Immun, 2005, 73(2): 999-1005. 被引量:1
  • 8Ann D, Charles HM, Susan MF, et al. Incident and persistent vulvovaginal candidiasis among human immunodeficiency virusinfected women: Risk Factors and Severity [J]. Obstet Gynecol,2003, 101(3): 548-556. 被引量:1
  • 9LeBlanc DM, Barousse MM, Fidel PL Jr. Role for dendritic cells in immunoregulation during experimental vaginal candidiasis [J ]. Infect Immun, 2006, 74(6): 3213-3221. 被引量:1
  • 10Moragues MD, Omaetxebarria MJ, Elguezabal N, et al. A monoclonal antibody directed against a candida albicans cell wall mannoprotein exerts three anti-C.albicans activities[J]. Infect Irmnun, 2003,71(9): 5273-5279. 被引量:1

共引文献586

同被引文献21

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部